S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 94 900 KRW 0.74% Market Closed
Market Cap: 1.9T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

ST Pharm Co Ltd
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ST Pharm Co Ltd
Accrued Liabilities Peer Comparison

Comparables:
207940
F
220100
L
141080
C
268600
E
456070

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
S
ST Pharm Co Ltd
KOSDAQ:237690
Accrued Liabilities
â‚©8.3B
CAGR 3-Years
67%
CAGR 5-Years
47%
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Accrued Liabilities
â‚©275.4B
CAGR 3-Years
67%
CAGR 5-Years
50%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Accrued Liabilities
â‚©979.8m
CAGR 3-Years
97%
CAGR 5-Years
26%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Accrued Liabilities
â‚©11.4B
CAGR 3-Years
246%
CAGR 5-Years
116%
CAGR 10-Years
64%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Accrued Liabilities
â‚©6.5B
CAGR 3-Years
N/A
CAGR 5-Years
128%
CAGR 10-Years
N/A
E
ENCell Co Ltd
KOSDAQ:456070
Accrued Liabilities
â‚©575m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ST Pharm Co Ltd's Accrued Liabilities?
Accrued Liabilities
8.3B KRW

Based on the financial report for Jun 30, 2024, ST Pharm Co Ltd's Accrued Liabilities amounts to 8.3B KRW.

What is ST Pharm Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
47%

Over the last year, the Accrued Liabilities growth was 273%. The average annual Accrued Liabilities growth rates for ST Pharm Co Ltd have been 67% over the past three years , 47% over the past five years .

Back to Top